Previous studies have shown the anti-cancer effect of fascaplysin through the suppression of CDK4 and cell cycle progression in various cancer cells [6,7,8,22], but the precise molecular mechanism by which fascaplysin attenuates cancer cell growth remained unexplored. This evidence concerns the gene CDK4 and cancer.